METTL3 and acute myeloid leukemia: In AML cells, expression of METTL3 mRNA and protein are more abundant than in healthy HSCs or other types of tumor cells, the depletion of which promotes cell differentiation and apoptosis and delays leukemia progression in mice (Vu et al., 2017).